Randall's plaques

Urinary Tract Stone Disease

Volumn , Issue , 2011, Pages 103-112

  Daudon, Michel ^a   Traxer, Olivier ^b   Williams Jr , James C ^c   Bazin, Dominique C ^d  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b HÔPITAL TENON   (France)

^c INDIANA UNIVERSITY   (United States)

^d UNIVERSITÉ PARIS SUD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84875586848     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-84800-362-0_7     Document Type: Chapter

References (44)

1. Randall A. An hypothesis for the origin of renal calculus. N Engl J Med. 1936;214:234-237.
2. Randall A. The origin and growth of renal calculi. Ann Surg. 1937;105:1009-1027.
3. Randall A. Papillary pathology as a precursor of primary renal calculus. J Urol. 1940;44:580-589.
4. Rosenow EC Jr. Renal calculi: study of papillary calcification. J Urol. 1940;44:19-23.
5. Anderson W A D. Renal calcification in adults. J Urol. 1940;44:29-34.
6. Vermooten V. The incidence and significance of the deposition of calcium plaques in the renal papilla as observed in the Caucasian and Bantu population in South Africa. J Urol. 1941;46:193-196.
7. Vermooten V. Origin and development in renal papilla of Randall's calcium plaques. J Urol. 1942;48:27-37.
8. Cifuentes Delatte L, Minon-Cifuentes JL, Medina JA. New studies on papillary calculi. J Urol. 1987;137:1024-1029.
9. Cifuentes Delatte L, Minon-Cifuentes JL, Medina JA. Papillary stones: calcified renal tubules in Randall's plaques. J Urol. 1985;133:490-494.
10. Daudon M, Traxer O, Jungers P, Bazin D. Stone morphology suggestive of Randall's plaque. in: Evan AP, Lingeman JE, Williams JC Jr, eds. Renal Stone Disease. Melville, NY: American Institute of Physics Conference Proceedings; 2007;900:26-34.
11. Daudon M. Epidemiology of nephrolithiasis in France. Ann Urol (Paris). 2005;39:209-231.
12. Low RK, Stoller ML. Endoscopic mapping of renal papillae for Randall's plaques in patients with urinary stone disease. J Urol. 1997;158:2062-2064.
13. Matlaga BR, Williams JC Jr, Kim SC, et al. Endoscopic evidence of calculus attachment to Randall's plaque. J Urol. 2006;175:1720-1724.
14. Kim SC, Coe FL, Tinmouth WW, et al. Stone formation is proportional to papillary surface coverage by Randall's plaque. J Urol. 2005;173:117-119.
15. Ruggera L, Chiodini S, Gambaro G, et al. Does Randall's plaque represent a necessary condition in the pathogenesis of the idiopathic calcium oxalate stones? Urol Res. 2008;36:162-163 (A).
16. Evan AP, Lingeman JE, Coe FL, et al. Randall's plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle. J Clin Invest. 2003;111:607-616.
17. Matlaga BR, Coe FL, Evan AP, et al. The role of Randall's plaques in the pathogenesis of calcium stones. J Urol. 2007;177:31-38.
18. Evan AP, Coe FL, Lingeman JE, et al. Mechanism of formation of human calcium oxalate renal stones on Randall's plaque. Anat Rec (Hoboken). 2007;290:1315-1323.
19. Evan AP, Coe FL, Rittling SR, et al. Apatite plaque particles in inner medulla of kidneys of calcium oxalate stone formers: osteopontin localization. Kidney Int. 2005;68:145-154.
20. Evan AP, Bledsoe S, Worcester EM, et al. Renal inter-alpha-trypsin inhibitor heavy chain 3 increases in calcium oxalate stone-forming patients. Kidney Int. 2007;72:1503-1511.
21. Evan A, Lingeman J, Coe FL, et al. Randall's plaque: pathogenesis and role in calcium oxalate nephrolithiasis. Kidney Int. 2006;69:1313-1318.
22. Evan AP, Lingeman JE, Coe FL, et al. Role of interstitial apatite plaque in the pathogenesis of the common calcium oxalate stone. Semin Nephrol. 2008;28:111-119.
23. Evan AP, Lingeman JE, Coe FL, et al. Crystal-associated nephropathy in patients with brushite nephrolithiasis. Kidney Int. 2005;67:576-581.
24. Evan AE, Lingeman JE, Coe FL, et al. Histopathology and surgical anatomy of patients with primary hyperparathyroidism and calcium phosphate stones. Kidney Int. 2008;74:223-229.
25. Meyer JL, Bergert JH, Smith LH. Epitaxial relationships in urolithiasis: the calcium oxalate monohydrate-hydroxyapatite system. Clin Sci Mol Med. 1975;49:369-374.
26. Khan SR. Calcium phosphate/calcium oxalate crystal association in urinary stones: implications for heterogeneous nucleation of calcium oxalate. J Urol. 1997;157:376-383.
27. Williams JC Jr, Matlaga BR, Kim SC, et al. Calcium oxalate calculi found attached to the renal papilla: Preliminary evidence for early mechanisms in stone formation. J Endourol. 2006;20:885-890.
28. Zarse CA, Hameed TA, Jackson ME, et al. CT visible internal stone structure, but not Hounsfield unit value, of calcium oxalate monohydrate (COM) calculi predicts lithotripsy fragility in vitro. Urol Res. 2007;35:201-206.
29. Zarse CA, McAteer JA, Sommer AJ, et al. Nondestructive analysis of urinary calculi using micro computed tomography. BMC Urol. 2004;4:15.
30. Kuo RL, Lingeman JE, Evan AP, et al. Urine calcium and volume predict coverage of renal papilla by Randall's plaque. Kidney Int. 2003;64:2150-2154.
31. Coe FL, Evan A, Worcester E. Kidney stone disease. J Clin Invest. 2005;115:2598-2608.
32. Curhan GC, Willett WC, Speizer FE, Stampfer MJ. Twenty-fourhour urine chemistries and the risk of kidney stones among women and men. Kidney Int. 2001;59:2290-2298.
33. Daudon M, Hennequin C, Boujelben G, et al. Serial crystalluria determination and the risk of recurrence in calcium stone formers. Kidney Int. 2005;67:1934-1943.
34. Bushinsky DA. Nephrolithiasis: site of the initial solid phase. J Clin Invest. 2003;111:602-605.
35. Sepe V, Adamo G, LaFianza A, et al. Henle loop basement membrane as initial site for Randall plaque formation. Am J Kidney Dis. 2006;48:706-711.
36. Halperin ML, Cheema Dhadli S, Kamel KS. Physiology of acidbase balance: links with kidney stone prevention. Semin Nephrol. 2006;26:441-446.
37. Hansell P, Goransson V, Odlind C, Gerdin B, Hallgren R. Hyaluronan content in the kidney in different states of body hydration. Kidney Int. 2000;58:2061-2068.
38. Verkoelen CF. Crystal retention in renal stone disease: a crucial role for the glycosaminoglycan hyaluronan? J Am Soc Nephrol. 2006;17:1673-1687.
39. Verkoelen CF. Hyaluronan in tubular and interstitial nephrocalcinosis. In: Evan AP, Lingeman JE, Williams JC Jr, eds. Renal Stone Disease. Melville, NY: American Institute of Physics Conference Proceedings; 2007;900:57-63.
40. Knepper MA, Saidel GM, Hascall VC, et al. Concentration of solutes in the renal inner medulla: interstitial hyaluronan as a mechano-osmotic transducer. Am J Physiol Renal Physiol. 2003;284:F433-446.
41. Raoult D, Drancourt M, Azza S, et al. Nanobacteria are mineralo fetuin complexes. PLoS Pathog. 2008;4:e41.
42. Gambaro G, D'Angelo A, Fabris A, et al. Crystals, Randall's plaques and renal stones: do bone and atherosclerosis teach us something? J Nephrol. 2004;17:774-777.
43. Daudon M, Bader CA, Jungers P. Urinary Calculi: Review of classification methods and correlations with etiology. Scanning Microsc. 1993;7:1081-1106.
44. Estepa L, Daudon M. Contribution of Fourier transform infrared spectroscopy to the identification of urinary stones and kidney crystal deposits. Biospectroscopy. 1997;3:347-369.